Ticker

Transaction expected to generate up to approximately $285 million in total cash value WEST CHICAGO, Ill., Sept. 21, 2026 /PRNewswire/ -- Titan International, Inc. (NYSE: TWI) ("Titan" or the "Company"), a leading global manufacturer of off-highway wheels, tires and undercarriage products, today announced that it has entered into a definitive agreement to sell its Italtractor ITM undercarriage business ("ITM") to…

MELBOURNE, Australia and INDIANAPOLIS and MUNICH, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE (“ITM”), a global leader in radioisotope production and radiopharmaceutical development.

Australia's Telix Pharmaceuticals ​said on ‌Monday it has ​agreed to ​acquire Germany-based ITM ⁠Isotope ​Technologies Munich SE ​for about $1.65 billion on a ​cash- ​and debt-free basis.

Treasury's pivot toward long-bond buybacks gives duration buyers their first clear green light in months — and the November midterms may add a second leg. Key takeaways Treasury's decision to at least double 10- to 30-year buybacks is a policy signal, not a technical footnote.

ITM Power PLC (AIM:ITM) said a £46.5 million grant from the Department for Energy Security and Net Zero has been formally awarded, giving the electrolyser maker public-sector backing for its next-generation Chronos manufacturing line in Sheffield. The grant, first announced in April, comes alongside a £40 million equity investment from Great British Energy.